Multicenter Trial Oversight
Multicenter Trial Oversight is a formal governance mechanism within research ethics oversight that coordinates and harmonizes ethical review processes across multiple institutional review boards or ethics committees involved in a single multisite clinical trial to ensure consistent application of ethical standards, regulatory compliance, and participant protection.
17
Publications
869
Citations
81
Authors
44
Institutions
Publications per year
2017–2026
2
17
The FDA's Critique of the Anturane Reinfarction Trial
Robert Temple, Gordon Pledger · New England Journal of Medicine · 1980 · 149 citations
Medicine, Cardiology, Pharmacology +17
1–5 of 17
81
2
h-index
1
h-index
1
h-index
1
h-index
University of North Carolina at Chapel Hill, United States
1 publications · 27 citations
1
h-index
1–5 of 81
44
Duke Medical Center
Durham, United States
2 h-index
3 publications
438 citations
Medical University of South Carolina
Charleston, United States
2 h-index
5 publications
214 citations

Johns Hopkins University
Baltimore, United States
2 h-index
5 publications
86 citations
New England Research Institutes
Watertown, United States
2 h-index
3 publications
218 citations

Icahn School of Medicine at Mount Sinai
New York, United States
1 h-index
1 publications
22 citations
Duke University
Durham, United States
1 h-index
2 publications
356 citations
Lahey Medical Center
Peabody, United States
1 h-index
1 publications
15 citations
Georgetown University
Washington, United States
1 h-index
1 publications
22 citations
1–8 of 44
2 publications · 38 citations
2
h-index
NEJM · 2 publications · 327 citations
2
h-index
2 publications · 29 citations
2
h-index
PM · 1 publications · 68 citations
1
h-index
1 publications · 153 citations
1
h-index
1–5